Colorectal cancer is the third most common cancer in the United States. There are an estimated 140,000 new cases diagnosed every year and about 50,000 people lose their lives to colorectal cancer each year. According to the American Cancer Society, the risk of developing colorectal cancer is slightly lower in women (4.15%) than in men (4.49%).
Click here for more information about Colorectal Cancer Awareness Month.
PathGroup recognizes the efforts of the American Heart Association and healthcare providers in identifying, diagnosing and managing patients at risk for and impacted by heart disease.
Click here for more information about American Heart Month.
BALTIMORE – (Monday, January 7, 2019) – Personal Genome Diagnostics Inc. (PGDx), a leader in cancer genomics, and PathGroup, a premier provider of anatomic, clinical and molecular laboratory services, announced today that they have entered into a co-development agreement for the PGDx elio™ tissue complete assay.
Click Here to read the press release.